KROS Key Financial Ratios - Keros Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	21.96	—	-28.91%	-31.70%
2026-03-31	22.62	—	-27.26%	-29.81%
2025-12-31	15.45	—	25.74%	28.70%
2025-09-30	29.86	—	8.68%	9.16%
2025-06-30	21.11	—	2.48%	2.66%
2025-03-31	19.29	—	0.54%	0.58%
2024-12-31	21.45	—	-30.42%	-32.78%
2024-09-30	19.03	—	-31.34%	-34.08%
2024-06-30	20.37	—	-36.93%	-39.93%
2024-03-31	24.74	—	-33.00%	-35.31%
2023-12-31	14.25	—	-41.35%	-46.05%
2023-09-30	18.23	—	-43.67%	-48.16%
2023-06-30	20.77	—	-35.51%	-38.78%
2023-03-31	23.43	—	-30.25%	-32.76%
2022-12-31	17.27	—	-34.12%	-37.73%
2022-09-30	21.33	—	-32.43%	-33.98%
2022-06-30	14.39	—	-34.72%	-37.26%
2022-03-31	19.85	—	-28.51%	-30.00%
2021-12-31	21.23	—	-23.01%	-24.16%
2021-09-30	20.52	—	-27.17%	-28.60%
2021-06-30	32.06	—	-22.27%	-23.01%
2021-03-31	28.6	—	-19.15%	-19.87%
2020-12-31	37.27	—	-16.84%	-17.33%
2020-09-30	19.99	—	-27.08%	-28.63%
2020-06-30	17.91	—	-19.24%	-20.48%
2020-03-31	6.63	—	-34.73%	84.63%
2019-12-31	1.99	—	-112.61%	63.44%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	15.45	—	25.74%	28.70%
2024-12-31	21.45	—	-30.42%	-32.78%
2023-12-31	14.25	—	-41.35%	-46.05%
2022-12-31	17.27	—	-34.12%	-37.73%
2021-12-31	21.23	—	-23.01%	-24.16%
2020-12-31	37.27	—	-16.84%	-17.33%
2019-12-31	1.99	—	-112.61%	63.44%